Advertisement
Letter| Volume 90, ISSUE 3, P367-368, June 2018

Reply: Lymph stasis promotes tumor growth

Published:February 15, 2018DOI:https://doi.org/10.1016/j.jdermsci.2018.02.011

      Abstract

      Our study suggested that surgical damage of the lymphatic system promotes tumor progression via impaired immune response. However, as pointed out by Valerio et al, lymph stasis is likely to induce immune stasis, resulting in not only enhanced tumor growth but also tumor generation. Although mechanisms of the tumor generation may not only include impaired immune response but also other factors induced by lymph stasis, we should avoid unnecessary lymphatic disruption in any surgeries and carefully consider the flap design to minimalize lymphatic disruption even in cases with benign tumors.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nakamura Y.
        • Fujisawa Y.
        • Okiyama N.
        • Watanabe R.
        • Tanaka R.
        • Ishitsuka Y.
        • Tahara H.
        • Fujimoto M.
        Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response.
        J. Dermatol. Sci. 2017;
        • Ruocco E.
        • Puca R.V.
        • Brunetti G.
        • Schwartz R.A.
        • Ruocco V.
        Lymphedematous areas: privileged sites for tumors, infections, and immune disorders.
        Int. J. Dermatol. 2007; 46: 662
        • Ruocco V.
        • Schwartz R.A.
        • Ruocco E.
        Lymphedema: an immunologically vulnerable site for development of neoplasms.
        J. Am. Acad. Dermatol. 2002; 47: 124-127
        • Domaszewska-Szostek A.
        • Zaleska M.
        • Olszewski W.L.
        Hyperkeratosis in human lower limb lymphedema: the effect of stagnant tissue fluid/lymph.
        J. Eur. Acad. Dermatol. Venereol.: JEADV. 2016; 30: 1002-1008
        • Zampell J.C.
        • Avraham T.
        • Yoder N.
        • Fort N.
        • Yan A.
        • Weitman E.S.
        • Mehrara B.J.
        Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines.
        Am. J. Physiol. Cell Physiol. 2012; 302: C392-404
        • Gousopoulos E.
        • Proulx S.T.
        • Bachmann S.B.
        • Dieterich L.C.
        • Scholl J.
        • Karaman S.
        • Bianchi R.
        • Detmar M.
        An important role of VEGF-C in promoting lymphedema development.
        J. Invest. Dermatol. 2017; 137: 1995-2004
        • De Vita V.
        • Ruocco E.
        Lymph stasis promotes tumor growth, Dermatolol.
        Sci. 2018;